Ibon Garitaonandia

Innothera (France) — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.7kcitations45works5.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pluripotent Stem Cells Research(23), CRISPR and Genetic Engineering(12), Biomedical Ethics and Regulation(8), Tissue Engineering and Regenerative Medicine(6), Mesenchymal stem cell research(5)

Publications45 total

Transendocardial Injection of Expanded Autologous CD34+ Cells After Myocardial Infarction
JACC Heart Failure·2025· 1 citedOpen Access
Validation of a potency assay for CD34 + cell based therapy
Scientific Reports·2025· 1 citedOpen Access
Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles
Stem Cells Translational Medicine·2024· 14 citedOpen Access
Probing Multiple Transplant Delivery Routes of CD+34 Stem Cells for Promoting Behavioral and Histological Benefits in Experimental Ischemic Stroke
Stem Cells Translational Medicine·2023· 10 citedOpen Access
Development of a potency assay for CD34+ cell-based therapy
Scientific Reports·2023· 6 citedOpen Access
Evaluation of expanded peripheral blood derived CD34+ cells for the treatment of moderate knee osteoarthritis
Frontiers in Bioengineering and Biotechnology·2023· 2 citedOpen Access
Development of a potency assay for CD34+ cell-based therapy for post-acute myocardial infarction
Research Square (Research Square)·2023Open Access
Kinetics of anti-SARS-CoV-2 IgG antibody levels and potential influential factors in subjects with COVID-19: A 11-month follow-up study
Diagnostic Microbiology and Infectious Disease·2021· 12 citedOpen Access
Can a second booster dose be delayed in patients who have had COVID-19?
2021· 1 citedOpen Access
Longitudinal analysis of COVID-19 infection rates and antibody levels pre- and post- vaccination
European Journal of Clinical Pharmacology·2021
Results of an Open Label, Dose Escalating, Phase 1 Clinical Trial Evaluating the Safety of a Human Neural Stem Cell Based Therapy in Parkinson’s Disease (P1.8-016)
Neurology·2019· 2 cited
Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model
Theranostics·2019· 36 citedOpen Access
Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells
Methods in molecular biology·2019· 9 cited
Novel Approach to Stem Cell Therapy in Parkinson's Disease
Stem Cells and Development·2018· 46 cited
Cover Image, Volume 12, Issue 5
Journal of Tissue Engineering and Regenerative Medicine·2018Open Access
Interim Clinical Assessment of a Neural Stem Cell Based Therapy for Parkinson’s Disease (S26.002)
Neurology·2018· 1 cited
Supplementation of specific carbohydrates results in enhanced deposition of chondrogenic-specific matrix during mesenchymal stem cell differentiation
Journal of Tissue Engineering and Regenerative Medicine·2018· 6 cited
PRELIMINARY RESULTS OF THE PHASE I CLINICAL STUDY EVALUATING NEURAL STEM CELL BASED THERAPY FOR PARKINSON’S DISEASE (S4.004)
Neurology·2017
Spontaneous Single-Copy Loss of <i>TP53</i> in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival
Stem Cells·2016· 43 citedOpen Access
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
Scientific Reports·2016· 72 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Rodolfo Gonzalez(18), Louise C. Laurent(16), Alexander Noskov(12), Andrey Semechkin(12), Tatiana Abramihina(11), Ruslan Semechkin(10), Russell Kern(10), Jeanne F. Loring(9), Ha Thi Thanh Tran(8), Francesca S. Boscolo(8), Maxim Poustovoitov(7), Glenn Sherman(7), Evan Snyder(7), Trevor R. Leonardo(6), Brian R. Kupchak(6), Thomas J. Lyons(6), Trudy Christiansen-Weber(6), Gerald Wambua(5), Jessica L. Smith(5), Suzanne E. Peterson(5)